Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanostol is a comprehensive multivitamin product line developed and marketed by DR. KADE Health Care. It encompasses various formulations, including syrups, gummy bears, and lozenges, designed for vitamin supplementation in both children and adults. The product line includes Multi-Sanostol, which is approved as a medicinal product for the prevention of combined vitamin deficiency states in children from one year of age. The formulations typically contain a blend of essential micronutrients, including vitamins A, C, D, E, and the B-complex (B1, B2, B6, B12, niacin, biotin, folic acid, and pantothenic acid), with some variants enriched with iron and calcium. These vitamins and minerals act as essential cofactors and regulators in numerous metabolic processes, supporting normal physiological functions and preventing nutritional deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanostol.